Art Taveras

Art Taveras

No más puestos en curso
62 años
Health Technology
Consumer Services
Commercial Services

Perfil

Dr. Art Taveras was previously employed as a Chief Scientific Officer by X4 Pharmaceuticals, Inc., a Chief Scientific Officer by Comet Therapeutics, Inc., a Chief Scientific Officer & Head-Drug Discovery by Transform Therapeutics, a President & Chief Scientific Officer by Shanghai ChemPartner Co., Ltd., a Vice President-Small Molecule Drug Discovery by Biogen Idec, Inc. (North Carolina), and a Vice President-Drug Discovery & Development by Alantos Pharmaceuticals Holding, Inc. He received his undergraduate degree from Rensselaer Polytechnic Institute, a graduate degree from Rensselaer Polytechnic Institute and a doctorate degree from Rensselaer Polytechnic Institute.

Antiguos cargos conocidos de Art Taveras.

EmpresasCargoFin
X4 PHARMACEUTICALS, INC. Director Técnico/Científico/I+D 01/01/2025
Transform Therapeutics
Fundador 01/11/2020
Director Técnico/Científico/I+D 01/07/2020
Presidente 01/12/2014
Corporate Officer/Principal 01/01/2013
Ver el detalle de la experiencia de Art Taveras.

Formación de Art Taveras.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

10

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Transform Therapeutics